CLINICAL_TRIALS
trial_result
· 2020-02-17
Clinical Trial Update: Nasal Gel Under Military Operational Conditions for the Prevention of Nausea Associated With Motion Sickness [Phase 3]
Summary
Phase 3 trial update on a nasal gel intended to prevent nausea from motion sickness under military operational conditions.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Repurposed Therapeutics, Inc. | Conditions: Motion Sickness | Phase 3 | Status: UNKNOWN